NM_025114.4:c.2217+45T>C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_025114.4(CEP290):c.2217+45T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00741 in 1,467,974 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0063   (  6   hom.,  cov: 32) 
 Exomes 𝑓:  0.0075   (  51   hom.  ) 
Consequence
 CEP290
NM_025114.4 intron
NM_025114.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.964  
Publications
0 publications found 
Genes affected
 CEP290  (HGNC:29021):  (centrosomal protein 290) This gene encodes a protein with 13 putative coiled-coil domains, a region with homology to SMC chromosome segregation ATPases, six KID motifs, three tropomyosin homology domains and an ATP/GTP binding site motif A. The protein is localized to the centrosome and cilia and has sites for N-glycosylation, tyrosine sulfation, phosphorylation, N-myristoylation, and amidation. Mutations in this gene have been associated with Joubert syndrome and nephronophthisis and the presence of antibodies against this protein is associated with several forms of cancer. [provided by RefSeq, Jul 2008] 
CEP290 Gene-Disease associations (from GenCC):
- CEP290-related ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
 - Joubert syndrome 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
 - Bardet-Biedl syndrome 14Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - Leber congenital amaurosis 10Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - Leber congenital amaurosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - Joubert syndrome with oculorenal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 - Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77). 
BP6
Variant 12-88111649-A-G is Benign according to our data. Variant chr12-88111649-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 261834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00634  AC: 965AN: 152152Hom.:  6  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
965
AN: 
152152
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00729  AC: 1209AN: 165742 AF XY:  0.00780   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1209
AN: 
165742
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00753  AC: 9908AN: 1315704Hom.:  51  Cov.: 21 AF XY:  0.00754  AC XY: 4934AN XY: 654774 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
9908
AN: 
1315704
Hom.: 
Cov.: 
21
 AF XY: 
AC XY: 
4934
AN XY: 
654774
show subpopulations 
African (AFR) 
 AF: 
AC: 
30
AN: 
26194
American (AMR) 
 AF: 
AC: 
145
AN: 
23190
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
245
AN: 
22538
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
34474
South Asian (SAS) 
 AF: 
AC: 
263
AN: 
66804
European-Finnish (FIN) 
 AF: 
AC: 
479
AN: 
51358
Middle Eastern (MID) 
 AF: 
AC: 
46
AN: 
5360
European-Non Finnish (NFE) 
 AF: 
AC: 
8297
AN: 
1031486
Other (OTH) 
 AF: 
AC: 
403
AN: 
54300
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 482 
 964 
 1445 
 1927 
 2409 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 304 
 608 
 912 
 1216 
 1520 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00634  AC: 965AN: 152270Hom.:  6  Cov.: 32 AF XY:  0.00649  AC XY: 483AN XY: 74468 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
965
AN: 
152270
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
483
AN XY: 
74468
show subpopulations 
African (AFR) 
 AF: 
AC: 
74
AN: 
41580
American (AMR) 
 AF: 
AC: 
119
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
47
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5192
South Asian (SAS) 
 AF: 
AC: 
12
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
93
AN: 
10596
Middle Eastern (MID) 
 AF: 
AC: 
2
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
595
AN: 
68002
Other (OTH) 
 AF: 
AC: 
22
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.495 
Heterozygous variant carriers
 0 
 44 
 87 
 131 
 174 
 218 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
4
AN: 
3468
ClinVar
Significance: Likely benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Aug 06, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.